Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9241 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9136 |
High Similarity |
NPD6959 |
Discontinued |
0.897 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.897 |
High Similarity |
NPD6166 |
Phase 2 |
0.897 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8938 |
High Similarity |
NPD1934 |
Approved |
0.8712 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8698 |
High Similarity |
NPD5844 |
Phase 1 |
0.869 |
High Similarity |
NPD7473 |
Discontinued |
0.8623 |
High Similarity |
NPD6232 |
Discontinued |
0.8553 |
High Similarity |
NPD1511 |
Approved |
0.8545 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8538 |
High Similarity |
NPD7074 |
Phase 3 |
0.8537 |
High Similarity |
NPD2801 |
Approved |
0.8503 |
High Similarity |
NPD5494 |
Approved |
0.848 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8466 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8447 |
Intermediate Similarity |
NPD1512 |
Approved |
0.843 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8424 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8412 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8382 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8315 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8291 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8291 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8214 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8208 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8204 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8166 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8161 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8136 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8136 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8125 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8079 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8049 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7939 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7939 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7939 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7937 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7923 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7865 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7811 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7805 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7803 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7797 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7797 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7751 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7688 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7688 |
Intermediate Similarity |
NPD943 |
Approved |
0.7669 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7669 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7658 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.765 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6780 |
Approved |
0.763 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7627 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD37 |
Approved |
0.7614 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7609 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD919 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7571 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7565 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7565 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7561 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7561 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7561 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7547 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7539 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7513 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD3748 |
Approved |
0.75 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7472 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7471 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.746 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.746 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7455 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD920 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7423 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7423 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7412 |
Intermediate Similarity |
NPD5401 |
Approved |
0.741 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7403 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7381 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7371 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6273 |
Approved |
0.736 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7321 |
Intermediate Similarity |
NPD1243 |
Approved |
0.731 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7286 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7268 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7251 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7234 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7208 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7143 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7108 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7108 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7079 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7062 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7056 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.705 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7035 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7031 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7031
|
Intermediate Similarity |
NPD2488 |
Approved |